[Comparison of clinical outcomes between antithymocyte globulin and basiliximab in renal transplantation from donation after citizen death: a matched pair study].

Lin, K L; Zhu, L; Fu, C; Lin, Z B; Chen, G

Lin, K L; Zhu, L; Fu, C; Lin, Z B; Chen, G.

Affiliation

Lin KL; Institute of Organ Transplantation, Tongji Hospital, Huazhong University of Science and Technology, Key Laboratory of Organ Transplantation, Ministry of Education, Key Laboratory of Organ Transplantation, Ministry of Public Health, Wuhan 430030, China.

Zhonghua Yi Xue Za Zhi ; 97(2): 99-103, 2017 Jan 10.

Article in Zh | MEDLINE | ID: mdl-28088952

Subject(s)

Kidney Transplantation; Antibodies, Monoclonal; Antilymphocyte Serum; Basiliximab; Delayed Graft Function; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Incidence; Recombinant Fusion Proteins; Retrospective Studies; Risk Factors; Tissue Donors

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Kidney Transplantation Type of study: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: Zh Journal: Zhonghua Yi Xue Za Zhi Year: 2017 Type: Article Affiliation country: China

Fulltext

XML

PubMed Links

Search on Google